JP2013544256A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544256A5
JP2013544256A5 JP2013540089A JP2013540089A JP2013544256A5 JP 2013544256 A5 JP2013544256 A5 JP 2013544256A5 JP 2013540089 A JP2013540089 A JP 2013540089A JP 2013540089 A JP2013540089 A JP 2013540089A JP 2013544256 A5 JP2013544256 A5 JP 2013544256A5
Authority
JP
Japan
Prior art keywords
pyridin
thiazol
amino
methyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544256A (ja
JP6005050B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061532 external-priority patent/WO2012068546A1/en
Publication of JP2013544256A publication Critical patent/JP2013544256A/ja
Publication of JP2013544256A5 publication Critical patent/JP2013544256A5/ja
Application granted granted Critical
Publication of JP6005050B2 publication Critical patent/JP6005050B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540089A 2010-11-19 2011-11-18 複素環式アミンおよびその使用 Active JP6005050B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41568510P 2010-11-19 2010-11-19
US61/415,685 2010-11-19
PCT/US2011/061532 WO2012068546A1 (en) 2010-11-19 2011-11-18 Heterocycle amines and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016171817A Division JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用

Publications (3)

Publication Number Publication Date
JP2013544256A JP2013544256A (ja) 2013-12-12
JP2013544256A5 true JP2013544256A5 (enExample) 2016-03-24
JP6005050B2 JP6005050B2 (ja) 2016-10-12

Family

ID=45094285

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013540089A Active JP6005050B2 (ja) 2010-11-19 2011-11-18 複素環式アミンおよびその使用
JP2016171817A Active JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用
JP2018059583A Active JP6726226B2 (ja) 2010-11-19 2018-03-27 複素環式アミンおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016171817A Active JP6316888B2 (ja) 2010-11-19 2016-09-02 複素環式アミンおよびその使用
JP2018059583A Active JP6726226B2 (ja) 2010-11-19 2018-03-27 複素環式アミンおよびその使用

Country Status (14)

Country Link
US (5) US9266874B2 (enExample)
EP (3) EP3357915A1 (enExample)
JP (3) JP6005050B2 (enExample)
KR (2) KR101903204B1 (enExample)
CN (2) CN103298792A (enExample)
ES (1) ES2672203T3 (enExample)
HK (1) HK1252165A1 (enExample)
HU (1) HUE037860T2 (enExample)
MX (3) MX366318B (enExample)
PL (1) PL2730564T3 (enExample)
PT (1) PT2730564T (enExample)
RS (1) RS57375B1 (enExample)
RU (2) RU2632900C2 (enExample)
WO (1) WO2012068546A1 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102971311B (zh) * 2010-05-06 2015-07-08 百时美施贵宝公司 作为gpr119调节剂的二环杂芳基化合物
EP2847215A1 (en) * 2012-05-07 2015-03-18 Synthes GmbH Methods and devices for treating intervertebral disc disease
CN104781251B (zh) * 2012-11-08 2016-12-14 百时美施贵宝公司 可作为激酶调节剂的经双环杂环取代的吡啶基化合物
EP3049086A4 (en) * 2013-09-27 2017-02-22 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US10266515B2 (en) * 2013-12-30 2019-04-23 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
IL311677B2 (en) * 2014-01-13 2025-06-01 Aurigene Oncology Ltd Bicyclic heterocyclyl derivatives as irak4 inhibitors
DK3286181T3 (da) 2015-04-22 2021-04-06 Rigel Pharmaceuticals Inc Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
EP3322409A4 (en) * 2015-07-15 2019-07-24 Aurigene Discovery Technologies Limited SUBSTITUTED AZA COMPOUNDS AS IRAQ-4 INHIBITORS
KR102670695B1 (ko) * 2015-09-18 2024-06-05 메르크 파텐트 게엠베하 Irak 억제제로서의 헤테로아릴 화합물 및 이의 용도
WO2017102091A1 (en) 2015-12-18 2017-06-22 Bayer Pharma Aktiengesellschaft Heteroarylbenzimidazole compounds
WO2017207534A1 (en) 2016-06-03 2017-12-07 Bayer Pharma Aktiengesellschaft Substituted heteroarylbenzimidazole compounds
TW202340194A (zh) 2017-02-16 2023-10-16 美商基利科學股份有限公司 吡咯并[1,2-b]嗒𠯤衍生物
CN120267671A (zh) 2017-03-31 2025-07-08 奥锐金肿瘤有限公司 用于治疗血液病的化合物和组合物
CN110785418A (zh) * 2017-06-21 2020-02-11 豪夫迈·罗氏有限公司 作为irak4调节剂的异二氢吲哚酮衍生物
MX2020003190A (es) 2017-09-22 2020-11-11 Kymera Therapeutics Inc Degradadores de proteinas y usos de los mismos.
WO2019060693A1 (en) 2017-09-22 2019-03-28 Kymera Therapeutics, Inc. CRBN LIGANDS AND USES THEREOF
EP4410377A3 (en) 2017-10-31 2024-11-13 Curis, Inc. Compounds and compositions for treating hematological disorders
WO2019111218A1 (en) 2017-12-08 2019-06-13 Cadila Healthcare Limited Novel heterocyclic compounds as irak4 inhibitors
IL315310A (en) 2017-12-26 2024-10-01 Kymera Therapeutics Inc Irak degraders and uses thereof
EP3737666A4 (en) 2018-01-12 2022-01-05 Kymera Therapeutics, Inc. PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES
US11512080B2 (en) 2018-01-12 2022-11-29 Kymera Therapeutics, Inc. CRBN ligands and uses thereof
US11292792B2 (en) 2018-07-06 2022-04-05 Kymera Therapeutics, Inc. Tricyclic CRBN ligands and uses thereof
US12454520B2 (en) 2018-07-06 2025-10-28 Kymera Therapeutics, Inc. Protein degraders and uses thereof
TWI721483B (zh) 2018-07-13 2021-03-11 美商基利科學股份有限公司 吡咯并[1,2-b]嗒𠯤衍生物
US12509455B2 (en) 2018-11-07 2025-12-30 Dana-Farber Cancer Institute, Inc. Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof
EP3876939A4 (en) 2018-11-07 2022-08-10 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
WO2020097396A1 (en) 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof
AU2019389174A1 (en) 2018-11-30 2021-07-01 Kymera Therapeutics, Inc. Irak degraders and uses thereof
PH12022500002A1 (en) 2019-06-28 2023-04-03 Kymera Therapeutics Inc Irak degraders and uses thereof
US12558427B2 (en) 2019-07-17 2026-02-24 Kymera Therapeutics, Inc. IRAK degraders and uses thereof
JP7573596B2 (ja) * 2019-07-23 2024-10-25 ブリストル-マイヤーズ スクイブ カンパニー Irak4阻害剤として有用なチエノピリジニルおよびチアゾロピリジニル化合物
JP2022545542A (ja) 2019-08-30 2022-10-27 ライジェル ファーマシューティカルズ, インコーポレイテッド ピラゾール化合物、その製剤並びに化合物及び/又は製剤を使用する方法
CA3156828A1 (en) 2019-10-03 2021-04-08 Dana-Farber Cancer Institute, Inc. Tricyclic kinase inhibitors and uses thereof
WO2021066573A1 (ko) * 2019-10-04 2021-04-08 파렌키마바이오텍 주식회사 신규 화합물 및 이의 자가면역질환 치료 용도
WO2021119159A1 (en) 2019-12-10 2021-06-17 Kymera Therapeutics, Inc. Irak degraders and uses thereof
CA3161878A1 (en) 2019-12-17 2021-06-24 Matthew M. Weiss Irak degraders and uses thereof
EP4076524A4 (en) 2019-12-17 2023-11-29 Kymera Therapeutics, Inc. IRAQ DEGRADERS AND USES THEREOF
TW202204350A (zh) 2020-05-06 2022-02-01 美商雅捷可斯治療公司 作為jak2抑制劑之6-雜芳基氧基苯并咪唑及氮雜苯并咪唑
EP4161521A4 (en) 2020-06-03 2024-07-10 Kymera Therapeutics, Inc. DEUTERED IRAQ DEGRADERS AND USES THEREOF
TW202210483A (zh) 2020-06-03 2022-03-16 美商凱麥拉醫療公司 Irak降解劑之結晶型
CA3194164A1 (en) 2020-09-30 2022-04-07 Koichiro Arai Pyrimidine- and nitrogen-containing bicyclic compound
US12577258B2 (en) 2020-09-30 2026-03-17 Vernalis (R&D) Limited Macrocyclic compound
EP4267574B1 (en) 2020-12-23 2025-04-23 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
AR124547A1 (es) 2020-12-30 2023-04-05 Kymera Therapeutics Inc Degradadores de irak y sus usos
MX2023009178A (es) 2021-02-15 2023-08-21 Kymera Therapeutics Inc Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos.
WO2022174268A1 (en) 2021-02-15 2022-08-18 Kymera Therapeutics, Inc. Irak4 degraders and uses thereof
WO2022187303A1 (en) 2021-03-03 2022-09-09 Rigel Pharmaceuticals, Inc. A method for treating a disease or condition using a pyrazole compound or formulation thereof
CA3214747A1 (en) 2021-04-08 2022-10-13 Reinhard Von Roemeling Combination therapies for the treatment of cancer
CA3217792A1 (en) 2021-05-07 2022-11-10 Kymera Therapeutics, Inc Cdk2 degraders and uses thereof
JP2024540080A (ja) 2021-10-29 2024-10-31 カイメラ セラピューティクス, インコーポレイテッド Irak4分解剤およびその合成
CA3234638A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
US12162881B2 (en) 2021-11-09 2024-12-10 Ajax Therapeutics, Inc. Forms and compositions of inhibitors of JAK2
EP4472967A4 (en) 2022-01-31 2026-04-15 Kymera Therapeutics Inc Iraqi Degradation Agents and Their Uses
ES3075943T3 (en) 2022-03-23 2026-08-10 Rigel Pharmaceuticals Inc Pyrimid-2-yl-pyrazole compounds as irak inhibitors
TW202345806A (zh) 2022-03-31 2023-12-01 美商艾伯維有限公司 噻唑并〔5,4-b〕吡啶malt-1抑制劑
JP2025522339A (ja) * 2022-06-01 2025-07-15 クダ セラピューティクス インコーポレイテッド イミダゾピリジン及びオキサゾロピリジン誘導体及びその類似体、その調製方法、HIF-1/2a経路阻害の方法、並びに、フェロトーシスの誘導
CN118239953A (zh) * 2022-12-23 2024-06-25 中国科学院合肥物质科学研究院 用于治疗PI3Kγ介导的疾病的化合物及其用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5542990B2 (enExample) * 1972-01-27 1980-11-04
JP3404749B2 (ja) 1996-06-27 2003-05-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ N―[4―(ヘテロアリールメチル)フェニル]―ヘテロアリールアミン
NZ503491A (en) 1997-11-10 2002-08-28 Bristol Myers Squibb Co 2-substituted amino-1,3-benzothiazole derivatives useful as protein tyrosine kinase inhibitors
JP2000086641A (ja) * 1998-09-11 2000-03-28 Kyorin Pharmaceut Co Ltd 2−置換ベンゾチアゾール誘導体及びその製造法
MXPA04009541A (es) * 2002-03-29 2005-01-25 Chiron Corp Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
US20040023978A1 (en) * 2002-07-24 2004-02-05 Yu Ren Active salt forms with tyrosine kinase activity
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
US20070066577A1 (en) * 2003-04-03 2007-03-22 Hea Young Park Choo Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
US7390907B2 (en) 2003-09-30 2008-06-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2005037285A1 (en) 2003-10-16 2005-04-28 Chiron Corporation 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
US7714009B2 (en) 2003-10-31 2010-05-11 Takeda Pharmaceutical Company Limited Nitrogen-containing fused heterocyclic compounds
GB0401334D0 (en) * 2004-01-21 2004-02-25 Novartis Ag Organic compounds
EP1674466A1 (en) 2004-12-27 2006-06-28 4Sc Ag 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
US7473784B2 (en) * 2005-08-01 2009-01-06 Bristol-Myers Squibb Company Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
KR20070052207A (ko) * 2005-11-16 2007-05-21 주식회사 엘지생명과학 신규한 kdr 억제제
CN101360707A (zh) * 2005-11-23 2009-02-04 利亘制药公司 血小板生成素活性调节化合物和方法
US20090298897A1 (en) * 2006-01-17 2009-12-03 Marina Cools Treatment of Inflammatory Disorders With Triazole Compounds
JP5236499B2 (ja) * 2006-01-27 2013-07-17 アレイ バイオファーマ、インコーポレイテッド グルコキナーゼ活性化剤
US20080293785A1 (en) * 2006-04-11 2008-11-27 Connolly Peter J Substituted benzothiazole kinase inhibitors
CN101558059B (zh) * 2006-08-11 2014-12-03 百时美施贵宝公司 丙型肝炎病毒抑制剂
NZ575410A (en) * 2006-09-07 2012-03-30 Biogen Idec Inc 2-(1H-Indazol-3-ylamino)-1H-benzimidazole derivatives
CN101594909A (zh) * 2006-09-07 2009-12-02 比奥根艾迪克Ma公司 用于治疗炎性病症、细胞增殖性失调、免疫失调的irak调节剂
JP2008255024A (ja) * 2007-04-02 2008-10-23 Banyu Pharmaceut Co Ltd ビアリールアミン誘導体
US20090258907A1 (en) 2008-04-09 2009-10-15 Abbott Laboratories Compounds useful as inhibitors of rock kinases
US20110105457A1 (en) * 2008-04-18 2011-05-05 Shionogi & Co., Ltd. Heterocyclic compound having inhibitory activity on pi3k
WO2010011964A2 (en) * 2008-07-24 2010-01-28 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying ad pathology
JP5177076B2 (ja) 2008-07-28 2013-04-03 日産自動車株式会社 車両運転支援装置及び車両運転支援方法
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物
US9067947B2 (en) * 2009-01-16 2015-06-30 Universal Display Corporation Organic electroluminescent materials and devices
EP2401273A1 (en) * 2009-02-27 2012-01-04 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
JP2012520845A (ja) * 2009-03-17 2012-09-10 グラクソ グループ リミテッド Itk阻害剤として使用されるピリミジン誘導体
US8765747B2 (en) * 2009-06-12 2014-07-01 Dana-Farber Cancer Institute, Inc. Fused 2-aminothiazole compounds
WO2011110575A1 (en) * 2010-03-11 2011-09-15 Glaxo Group Limited Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
WO2012035055A1 (en) * 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
PL3536685T3 (pl) 2014-04-04 2022-05-16 Pfizer Inc. Bicykliczne skondensowane związki heteroarylowe lub arylowe i ich zastosowanie jako inhibitory IRAK4

Similar Documents

Publication Publication Date Title
RU2013124101A (ru) Гетероциклические амины и их применения
HRP20210094T1 (hr) POSTUPAK PRIPRAVE DERIVATIVA OKSAZOLO[4,5-b]PIRIDINA I TIAZOLO[4,5-b]PIRIDINA KAO INHIBITORA IRAK4 NAMIJENJENIH LIJEČENJU RAKA
JP7028861B2 (ja) ピリジル置換のインドール化合物
AU2016240033B2 (en) 1-cyano-pyrrolidine compounds as USP30 inhibitors
KR101819433B1 (ko) 인돌린-2-온 또는 피롤로-피리딘-2-온 유도체
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
CA3211347A1 (en) Indazole based compounds and associated methods of use
JP4968860B2 (ja) アニリノピペラジン誘導体およびアニリノピペラジン誘導体を使用する方法
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
KR20200131246A (ko) 키나제 억제제로서의 헤테로시클릭 화합물
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
JP2014521711A5 (enExample)
JPWO2005063743A1 (ja) チアゾール誘導体
JP2014501269A5 (enExample)
US20160060222A1 (en) Amino-quinolines as kinase inhibitors
JP2013533300A (ja) ブルトン型チロシンキナーゼの阻害剤
JP2012525395A5 (enExample)
JP2005526814A5 (enExample)
WO2017210545A1 (en) Potassium channel modulators
JP2018520201A5 (enExample)
HRP20221454T1 (hr) Piridinamin-piridonski i pirimidinamin-piridonski spojevi
IL274198B2 (en) Use of Nox inhibitors to treat cancer
JP2023546352A (ja) Bcr-ablチロシンキナーゼの阻害のための5-及び6-アザインドール化合物
WO2024184550A1 (en) Biarylamide derivatives and their use as pkmyt1 inhibitors
JPWO2020203609A5 (enExample)